CD146 is a potential immunotarget for neuroblastoma.
Obu S, Umeda K, Ueno H, Sonoda M, Tasaka K, Ogata H, Kouzuki K, Nodomi S, Saida S, Kato I, Hiramatsu H, Okamoto T, Ogawa E, Okajima H, Morita K, Kamikubo Y, Kawaguchi K, Watanabe K, Iwafuchi H, Yagyu S, Iehara T, Hosoi H, Nakahata T, Adachi S, Uemoto S, Heike T, Takita J.
Obu S, et al. Among authors: kouzuki k.
Cancer Sci. 2021 Nov;112(11):4617-4626. doi: 10.1111/cas.15124. Epub 2021 Sep 30.
Cancer Sci. 2021.
PMID: 34464480
Free PMC article.